| Rezolute, Inc. |
CFO |
Common Shares |
416K |
$734K |
$1.77 |
15 Dec 2025 |
Direct |
| Rezolute, Inc. |
CFO |
Common Shares |
40K |
$382K |
$9.56 |
15 Dec 2025 |
Held by PoC Capital LLC |
| NEPHROS INC |
CEO Specialty Renal Products |
Common Stock |
134K |
$296K |
$2.20 |
24 May 2021 |
Direct |
| Rezolute, Inc. |
CFO |
Common Shares |
23K |
$220K |
$9.56 |
15 Dec 2025 |
Held by minor child #1 |
| Rezolute, Inc. |
CFO |
Common Shares |
20K |
$191K |
$9.56 |
15 Dec 2025 |
Held by spouse |
| NEPHROS INC |
CEO Specialty Renal Products |
Common Stock |
8.95K |
$19.7K |
$2.20 |
27 May 2021 |
By UTMA #1 |
| NEPHROS INC |
CEO Specialty Renal Products |
Common Stock |
8.67K |
$19.1K |
$2.20 |
27 May 2021 |
By UTMA #2 |
| NEPHROS INC |
CEO Specialty Renal Products |
Common Stock |
6.11K |
$13.5K |
$2.20 |
24 May 2021 |
By PoC Capital, LLC |
| Rezolute, Inc. |
CFO |
Common Shares |
7K |
$12.5K |
$1.79 |
15 Dec 2025 |
Held by minor child #3 |
| Rezolute, Inc. |
CFO |
Common Shares |
7K |
$12.5K |
$1.79 |
15 Dec 2025 |
Held by minor child #2 |
| NEPHROS INC |
CEO Specialty Renal Products |
Common Stock |
888 |
$1.96K |
$2.20 |
24 May 2021 |
By UTMA #3 |
| NEPHROS INC |
CEO Specialty Renal Products |
Common Stock |
888 |
$1.96K |
$2.20 |
24 May 2021 |
By UTMA #4 |
| Rezolute, Inc. |
CFO |
Employee Stock Option (Right to Buy) |
63K |
|
|
19 Nov 2025 |
Direct |
| NEPHROS INC |
CEO Specialty Renal Products |
Stock Option (Right to Buy) |
20K |
|
|
24 May 2021 |
Direct |
| NEPHROS INC |
CEO Specialty Renal Products |
Common Stock Warrants (Right to Buy) |
0 |
|
|
24 May 2021 |
By UTMA #1 |
| NEPHROS INC |
CEO Specialty Renal Products |
Common Stock Warrants (Right to Buy) |
0 |
|
|
24 May 2021 |
By UTMA #2 |